Patton Fund Management Inc. Reduces Stock Position in Teradyne, Inc. $TER

Patton Fund Management Inc. decreased its position in Teradyne, Inc. (NASDAQ:TER) by 64.8% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 15,077 shares of the company’s stock after selling 27,814 shares during the quarter. Teradyne comprises about 0.8% of Patton Fund Management Inc.’s holdings, making the stock its 21st largest position. Patton Fund Management Inc.’s holdings in Teradyne were worth $4,470,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. ARK Investment Management LLC raised its position in shares of Teradyne by 25.2% in the third quarter. ARK Investment Management LLC now owns 2,722,327 shares of the company’s stock valued at $374,701,000 after buying an additional 548,140 shares during the last quarter. Nordea Investment Management AB boosted its position in Teradyne by 656.4% during the fourth quarter. Nordea Investment Management AB now owns 125,312 shares of the company’s stock worth $24,554,000 after acquiring an additional 108,745 shares during the last quarter. Gouws Capital LLC grew its stake in Teradyne by 96.0% in the 4th quarter. Gouws Capital LLC now owns 15,323 shares of the company’s stock worth $2,966,000 after acquiring an additional 7,505 shares during the period. Assenagon Asset Management S.A. grew its stake in Teradyne by 3,233.4% in the 4th quarter. Assenagon Asset Management S.A. now owns 910,023 shares of the company’s stock worth $176,144,000 after acquiring an additional 882,723 shares during the period. Finally, Wealthfront Advisers LLC raised its holdings in Teradyne by 56.0% in the 4th quarter. Wealthfront Advisers LLC now owns 29,336 shares of the company’s stock valued at $5,678,000 after acquiring an additional 10,526 shares during the last quarter. 99.77% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research analysts have weighed in on the company. Morgan Stanley set a $387.00 price target on Teradyne in a research note on Thursday, April 30th. Zacks Research raised Teradyne from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, May 12th. Citigroup upped their target price on Teradyne from $325.00 to $400.00 and gave the company a “buy” rating in a research note on Thursday, April 30th. Stifel Nicolaus increased their target price on Teradyne from $325.00 to $390.00 and gave the stock a “buy” rating in a research report on Tuesday, April 28th. Finally, UBS Group raised their price target on Teradyne from $325.00 to $440.00 and gave the stock a “buy” rating in a research note on Tuesday, April 21st. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, Teradyne currently has an average rating of “Moderate Buy” and a consensus target price of $363.87.

Teradyne Price Performance

NASDAQ:TER opened at $436.86 on Monday. The company has a market cap of $68.39 billion, a P/E ratio of 80.90, a P/E/G ratio of 1.26 and a beta of 1.79. Teradyne, Inc. has a fifty-two week low of $88.60 and a fifty-two week high of $472.37. The firm’s 50 day moving average is $382.07 and its two-hundred day moving average is $309.48.

Teradyne (NASDAQ:TER) last announced its quarterly earnings data on Wednesday, April 29th. The company reported $2.56 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.11 by $0.45. The company had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.20 billion. Teradyne had a net margin of 22.55% and a return on equity of 31.79%. The business’s quarterly revenue was up 87.0% compared to the same quarter last year. During the same period in the previous year, the company earned $0.75 EPS. Research analysts forecast that Teradyne, Inc. will post 7.2 earnings per share for the current fiscal year.

Teradyne Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Shareholders of record on Thursday, May 21st were paid a dividend of $0.13 per share. This is a boost from Teradyne’s previous quarterly dividend of $0.12. This represents a $0.52 annualized dividend and a yield of 0.1%. The ex-dividend date was Thursday, May 21st. Teradyne’s payout ratio is currently 9.63%.

Insiders Place Their Bets

In other news, VP Ryan Driscoll sold 680 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $377.60, for a total transaction of $256,768.00. Following the completion of the sale, the vice president owned 7,665 shares in the company, valued at approximately $2,894,304. The trade was a 8.15% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Shannon John Poulin sold 656 shares of the business’s stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $355.00, for a total value of $232,880.00. Following the sale, the insider owned 15,722 shares of the company’s stock, valued at $5,581,310. The trade was a 4.01% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 14,941 shares of company stock worth $5,444,112 over the last three months. 0.19% of the stock is owned by insiders.

Trending Headlines about Teradyne

Here are the key news stories impacting Teradyne this week:

• Positive Sentiment: Teradyne’s AI-driven robotics revenue is growing quickly, with new partnerships and a key e-commerce customer expected to scale in 2026, which supports the case for additional upside. Teradyne Drives Robotics Growth With AI: A Sign for More Upside?
• Positive Sentiment: A major customer’s strong earnings report boosted investor confidence that demand tied to Teradyne’s testing and automation equipment remains solid, helping push the shares to fresh highs. Teradyne (TER) Hits All-Time High as Major Customer Reports Stellar Earnings
• Positive Sentiment: Analyst commentary remains broadly constructive, with Wall Street brokerage recommendations still leaning bullish on Teradyne. Wall Street Bulls Look Optimistic About Teradyne (TER): Should You Buy?
• Neutral Sentiment: Teradyne rings the opening bell, a visibility and branding event that is unlikely to materially affect fundamentals but can highlight the company’s market profile. Teradyne Rings the Opening Bell
• Neutral Sentiment: Teradyne expanded its India focus by naming a new country manager, a strategic operating move that may support long-term growth but is not an immediate stock catalyst. Teradyne expands India focus with new country manager
• Negative Sentiment: One article questioned whether Teradyne’s AI momentum has run too far, reflecting some concern that the stock’s strong rally may be getting ahead of fundamentals. Is Teradyne (NASDAQ:TER) AI Momentum Running Too Far?

Teradyne Company Profile

Teradyne, Inc is a global supplier of automatic test equipment and related services principally used to test semiconductors, wireless products and complex electronic systems. Founded in 1960, the company is headquartered in North Reading, Massachusetts, and has a long history of developing capital equipment and software that help semiconductor manufacturers, electronics OEMs and contract manufacturers validate product performance and reliability during design and production.

The company’s product portfolio centers on automatic test equipment (ATE) and system-level test solutions that address chip- and board-level validation, burn-in and reliability screening.